Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nyxoah SA

7.74
-0.0100-0.13%
Post-market: 7.740.00000.00%16:58 EDT
Volume:18.09K
Turnover:140.42K
Market Cap:289.69M
PE:-3.59
High:7.86
Open:7.76
Low:7.71
Close:7.75
Loading ...

Company Profile

Company Name:
Nyxoah SA
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
184
Office Location:
Rue Edouard Belin 12,Mont-Saint-Guibert,Walloon Brabant,Belgium
Zip Code:
1435
Fax:
32 1 045 90 75
Introduction:
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Directors

Name
Position
Olivier Taelman
Executive Director,Chief Executive Officer
Robert Taub
Non-Executive Director,Chairman of the Board
Donald Deyo
Non-Executive Director
Jan Janssen
Non-Executive Director
Janke Dittmer
Non-Executive Director
Jurgen Hambrecht
Non-Executive Director
Kevin Rakin
Non-Executive Director
Pierre Gianello
Non-Executive Director

Shareholders

Name
Position
Olivier Taelman
Executive Director,Chief Executive Officer
Fabian Suarez Gonzalez
Chief Financial Officer